Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: We investigated the association between 52 risk variants identified through genome-wide association studies and disease severity in multiple sclerosis (MS).
Methods: Ten unique MS case data sets were analyzed. The Multiple Sclerosis Severity Score (MSSS) was calculated using the Expanded Disability Status Scale at study entry and disease duration. MSSS was considered as a continuous variable and as 2 dichotomous variables (median and extreme ends; MSSS of ≤5 vs >5 and MSSS of <2.5 vs ≥7.5, respectively). Single nucleotide polymorphisms (SNPs) were examined individually and as both combined weighted genetic risk score (wGRS) and unweighted genetic risk score (GRS) for association with disease severity. Random-effects meta-analyses were conducted and adjusted for cohort, sex, age at onset, and HLA-DRB1*15:01.
Results: A total of 7,125 MS cases were analyzed. The wGRS and GRS were not strongly associated with disease severity after accounting for cohort, sex, age at onset, and HLA-DRB1*15:01. After restricting analyses to cases with disease duration ≥10 years, associations were null (p value ≥0.05). No SNP was associated with disease severity after adjusting for multiple testing.
Conclusions: The largest meta-analysis of established MS genetic risk variants and disease severity, to date, was performed. Results suggest that the investigated MS genetic risk variants are not associated with MSSS, even after controlling for potential confounders. Further research in large cohorts is needed to identify genetic determinants of disease severity using sensitive clinical and MRI measures, which are critical to understanding disease mechanisms and guiding development of effective treatments.
GLOSSARY
- CI=
- confidence interval;
- EAE=
- experimental autoimmune encephalomyelitis;
- EDSS=
- Expanded Disability Severity Scale;
- GRS=
- unweighted genetic risk score;
- GWAS=
- genome-wide association studies;
- KPNC=
- Kaiser Permanente Medical Care Plan in the Northern California Region;
- MHC=
- major histocompatibility complex;
- MS=
- multiple sclerosis;
- MSSS=
- Multiple Sclerosis Severity Score;
- OR=
- odds ratio;
- SNP=
- single nucleotide polymorphism;
- UCSF=
- University of California at San Francisco;
- wGRS=
- weighted genetic risk score
Footnotes
Funding information and disclosures are provided at the end of the article. Go to Neurology.org/ng for full disclosure forms. The Article Processing Charge was paid by the authors.
Supplemental data at Neurology.org/ng
- Received December 4, 2015.
- Accepted in final form June 16, 2016.
- © 2016 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MSMilena A. Gianfrancesco, Pernilla Stridh, Brooke Rhead et al.Neurology, March 29, 2017 -
Article
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F. Harbo et al.Neurology, June 14, 2013 -
Article
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis riskBrooke Rhead, Maria Bäärnhielm, Milena Gianfrancesco et al.Neurology: Genetics, September 13, 2016 -
Articles
APOE epsilon variation in multiple sclerosis susceptibility and disease severitySome answersR. M. Burwick, P. P. Ramsay, J. L. Haines et al.Neurology, May 08, 2006